🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase Ib partially blinded pilot study to evaluate the safety and immunol...
Status
Completed
Location
University of Pennsylvania. Clinical Trials Unit
Start Date
2008-09
Trial ID
NCT00775424
Treatments Being Tested
The central premise of our program is that durable control of HIV in the ab...
Status
Completed
Location
University of California, Los Angeles
Start Date
2018-08-01
Trial ID
NCT03606213
Treatments Being Tested
The aim of this study is to assess the potential benefit of the addition of...
Status
Withdrawn
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2016-05
Trial ID
NCT02501278
Background: \- In most people who have human immunodeficiency virus (HIV),...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-05-10
Trial ID
NCT01859325
Treatments Being Tested
Some vaccines may work better when given together with another substance kn...
Status
Completed
Location
Columbia P&S CRS
Start Date
2012-05
Trial ID
NCT01578889
An effective vaccine may be the only way to stop the HIV pandemic. The purp...
Status
Completed
Location
Univ. of Rochester HVTN CRS
Start Date
2009-11
Trial ID
NCT00991354
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Bridge HIV CRS
Start Date
2017-10-18
Trial ID
NCT03181789
This is a randomized, adaptive, open label, multicenter trial to evaluate t...
Status
Recruiting
Location
Advent Health
Start Date
2025-07-09
Trial ID
NCT06915025
The study will evaluate the safety and tolerability of the PENNVAX®-GP HIV-...
Status
Completed
Location
The Hope Clinic of the Emory Vaccine Center CRS
Start Date
2015-08
Trial ID
NCT02431767
Treatments Being Tested
The primary purpose of this study is to evaluate the safety of a peptide-ge...
Status
Completed
Location
Hematology-Oncology & SCT Research Center
Start Date
2008-02
Trial ID
NCT00455221
Treatments Being Tested